Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Oncotherapy Regulatory News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Sep 2018 11:52

RNS Number : 1504A
Advanced Oncotherapy PLC
07 September 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Advanced Oncotherapy Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

ü

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Mr Alberto Colussi

City and country of registered office (if applicable)

Stansstad, Switzerland

4. Full name of shareholder(s) (if different from 3.)v

Name

Brahma AG

City and country of registered office (if applicable)

Buochs, Switzerland

5. Date on which the threshold was crossed or reachedvi:

3 September 2018

6. Date on which issuer notified (DD/MM/YYYY):

5 September 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4,67%

4,67%

169,566,092

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares (GBP 0.25)

 

GB00BD6SX109

7,927,000

4.67%

SUBTOTAL 8. A

7,927,000

4.67%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Stansstad

Date of completion

September 5th 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUBSRRWKAKRAR
Date   Source Headline
8th Jul 201511:41 amRNSHolding(s) in Company
2nd Jul 20157:00 amRNSCommencement of initial SCDTL testing
1st Jul 20152:08 pmRNSDirector Dealing & Total Voting Rights
29th Jun 201511:08 amRNSResult of AGM
8th Jun 20157:00 amRNSDirector/PDMR Shareholding
4th Jun 20157:00 amRNSDirector/PDMR Shareholding
3rd Jun 20157:00 amRNSFinal Results
26th May 20152:38 pmRNSHolding(s) in Company
20th May 201512:20 pmRNSNotice of Results
19th May 20157:00 amRNSSuccessful RF power testing of the first CCL unit
15th May 20157:00 amRNSExercise of Warrants
11th May 201511:27 amRNSHolding(s) in Company
1st May 20157:00 amRNSPlacing
27th Apr 20157:00 amRNSExercise of Warrants
20th Apr 20157:00 amRNSStmnt re Share Price Movement
9th Apr 20155:42 pmRNSHolding(s) in Company
8th Apr 20157:00 amRNSExercise of Warrants
2nd Apr 201512:48 pmRNSUpdate on ScandiNova collaboration
25th Mar 20157:00 amRNSFirst commercial sale of LIGHT machine in China
12th Mar 20157:00 amRNSLoan agreement
2nd Mar 20157:00 amRNSSale of Southampton property
19th Feb 20157:00 amRNSExercise of warrants and conversion of debt
5th Feb 20157:00 amRNSDirector/PDMR Shareholding
4th Feb 20158:52 amRNSCorrection - Director/PDMR Shareholding
4th Feb 20157:00 amRNSDirector/PDMR Shareholding
28th Jan 20157:00 amRNSLondon Harley Street Proton Therapy Centre
26th Jan 20157:00 amRNSManufacturing of CCL module complete
20th Jan 20157:00 amRNSEstablishment of CERN Scientific Review Board
12th Jan 20157:00 amRNSSupply agreement with Pyramid
2nd Dec 20147:00 amRNSExclusivity agreement signed
25th Nov 20147:00 amRNSManufacturing Agreement for CCL
18th Nov 20147:00 amRNSInvestor Presentation
4th Nov 20142:54 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSInvestor Presentation
27th Oct 20147:00 amRNSJoint MOU with TECHNA Institute and TERA
20th Oct 20146:29 pmRNSCorrection: Director Dealing
20th Oct 201410:17 amRNSDirector Dealing
17th Oct 20147:00 amRNSConversion of Loans
9th Oct 20147:00 amRNSDirectorate Change
3rd Oct 20145:51 pmRNSHolding(s) in Company
3rd Oct 20147:00 amRNSDirector share purchase & Issue of Equity
1st Oct 20142:21 pmRNSAward of Options and Director Dealing
29th Sep 20147:00 amRNSHalf Yearly Report
25th Sep 20144:00 pmRNSExercise of Warrants
18th Sep 20143:17 pmRNSHolding(s) in Company
10th Sep 20147:00 amRNSIssue of Equity
4th Sep 201410:26 amRNSHolding(s) in Company
27th Aug 20147:00 amRNSAppointment of Nicolas Serandour
14th Aug 20147:00 amRNSStrategic Partnership with Toshiba
8th Aug 20147:00 amRNSIssue of Equity and Warrants and director deal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.